Document is current
Any future updates will be listed below
-
Authors
Manabe, Yusuke
Ishibashi, Tomohiko
Asano, Ryotaro
Tonomura, Shuichi
Maeda, Yuichi
Motooka, Daisuke
Ueda, Jin
Yanagawa, Masahiro
Edamoto-Taira, Yuko
Chikaishi-Kirino, Tomomi
Masaki, Takeshi
Inagaki, Tadakatsu
Nakamura, Shota
Katada, Yoshinori
Okazawa, Makoto
Narazaki, Masashi
Ogo, Takeshi
Kumanogoh, Atsushi
Nakaoka, Yoshikazu http://orcid.org/0000-0002-8404-2587
- License Information
-
More Information
Article History
Received: 12 November 2022
Accepted: 16 March 2023
First Online: 24 March 2023
Declarations
:
: Approval was obtained from the research ethics committees of the National Cerebral and Cardiovascular Center (R19060-4, M30-072–4), Osaka University Hospital (19317), and Suita Municipal Hospital (2020-ken 30). Written informed consent was obtained from all of the participants.
: Consent for publication was obtained from all of the participants.
: Y. Maeda has received a research grant and/or speaker fee from Chugai, Pfizer, and Mitsubishi-Tanabe. M. N. has received a grant and payment from the Department of Advanced Clinical and Translational Immunology, Osaka University Graduate School of Medicine, which is collaborating with Chugai. T. O. has received lecture fees from Janssen Pharmaceutical K.K., Nippon Shinyaku Co., Pfizer Japan Inc., and Bayer Yakuhin Ltd., and research grants from Mochida Pharmaceutical Co. A. K. has received lecture fees and research grants from Chugai. Y. N. has received consulting fees and lecture fees, and research grants from Chugai, consulting fees and lecture fees from AbbVie, and consulting fees from Janssen Pharmaceuticals K.K. All other authors have no conflict of interests to disclose.
